Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Beta-Interferon Inhibits Tumor Growth

April 7, 2010 6:02 am | News | Comments

The human body has developed various mechanisms, through which it can protect itself against newly-developing cancer cells.


Scientists Explore Aggregation of Parkinson's Biomarker

April 7, 2010 5:57 am | News | Comments

Although the cause of Parkinson's disease remains a mystery, scientists now have a better understanding of the earliest stages of abnormal aggregation of a key disease-associated protein.


Fruits And Vegetables Do Little To Prevent Cancer

April 7, 2010 5:50 am | News | Comments

An analysis by Mount Sinai researchers of over eight years of dietary data from more than 400,000 people has found that the relationship between high consumption of fruits and vegetables and a reduced risk of cancer is not as strong as commonly thought.


Seasonal Flu Vaccine May Have Raised Swine Flu Risk

April 7, 2010 5:44 am | News | Comments

In September 2009, news stories reported that researchers in Canada had found an increased risk of pandemic H1N1 influenza in people who had previously been vaccinated against seasonal influenza.


Rush Researchers Testing Melanoma Vaccine

April 7, 2010 5:39 am | News | Comments

Rush University Medical Center is leading a nationwide Phase 3 clinical trial to determine whether a promising vaccine for advanced melanoma can effectively treat the deadly skin cancer.


Appelate Court Upholds AstraZeneca Ruling

April 7, 2010 5:32 am | by Linda A. Johnson | News | Comments

A federal appellate court has upheld a lower court ruling dismissing the first product liability lawsuit among thousands alleging British drugmaker AstraZeneca PLC's antipsychotic drug Seroquel triggered a patient's diabetes.


FDA Approves Abuse-Resistant OxyContin

April 7, 2010 5:29 am | News | Comments

The Food and Drug Administration has approved a new version of the painkiller OxyContin designed to be harder for patients to abuse, but one of the regulator's doctors said it may offer only "an incremental advantage."


Davunetide Receives FDA Fast Track Status

April 6, 2010 8:47 am | News | Comments

Allon Therapeutics' lead neuroprotective drug candidate, davunetide, has been granted Fast Track status from the FDA for the treatment of Progressive Supranuclear Palsy.


Upright Clinical Microscope

April 6, 2010 6:31 am | Product Releases | Comments

Olympus has unveiled its BX3 line of upright clinical and research microscopes with exclusive ergonomic and imaging features that provide unprecedented comfort, ease of use and accuracy.


Benchtop Bioreactor

April 6, 2010 6:27 am | Product Releases | Comments

The Automation Partnership (TAP), a leader in the design and development of innovative automation for life science applications, is pleased to announce its new advanced micro bioreactor system (ambr).


Poisoning Second Leading Cause of Unintentional Death

April 6, 2010 6:10 am | News | Comments

While several recent high-profile Hollywood celebrity cases have brought the problem to public attention, the rates of unintentional poisoning deaths have been on the rise for more than 15 years.


ICG A Boon to Stem Cell Tracking

April 6, 2010 5:59 am | News | Comments

A recent study has found that using the contrast agent Indocyanine Green to label human embryonic stem cell-derived cardiomyocytes substantially improved efforts to optically track stem cells after transplanting them into heart tissues.


Andrea Barry Joins CCD

April 6, 2010 5:37 am | News | Comments

With the addition of big pharma and government laboratories to the community, the company has brought on board Andrea Barry as senior director of business development to drive this growing commercial initiative.


BioAlliance Licenses Drugs to Therabel Group

April 6, 2010 5:32 am | News | Comments

BioAlliance Pharma SA announced an exclusive partnership agreement with Therabel Group for the European commercialization rights of Loramyc and Setofilm.


Lithium of No Use in ALS

April 6, 2010 5:23 am | by Maria Cheng | News | Comments

Lithium doesn't help patients with ALS, or Lou Gehrig's disease, contrary to previous study results, new research says.



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.